First_NP Report_NP on_IN Schizophyllum_NP commune_NN from_IN a_DT Dog_NP This_DT report_NN describes_VBZ the_DT first_JJ isolation_NN of_IN Schizophyllum_NP commune_NN from_IN a_DT granulomatous_JJ lesion_NN on_IN the_DT neck_NN of_IN a_DT dog_NN ._SENT The_DT biopsy_NN specimen_NN from_IN the_DT lesion_NN disclosed_VBD granulomatous_JJ inflammation_NN with_IN branching_VBG fungal_JJ hyphae_NNS without_IN clamp_NN connections_NNS ._SENT The_DT clinical_JJ isolate_NN was_VBD identified_VBN as_IN S._NP commune_NN by_IN mycological_JJ examination_NN and_CC analysis_NN of_IN ribosomal_JJ DNA_NN sequences_NNS ._SENT A_DT 3-year-old_JJ male_JJ mongrel_NN dog_NN weighing_VBG 10_CD kg_NN was_VBD referred_VBN to_TO the_DT Minami_NP Animal_NP Hospital_NP in_IN Mie_NP ,_, Japan_NP ,_, with_IN the_DT chief_JJ complaint_NN of_IN a_DT subcutaneous_JJ nodule_NN on_IN the_DT ventral_JJ surface_NN of_IN the_DT neck_NN ._SENT This_DT subcutaneous_JJ nodule_NN with_IN no_DT fistula_NN and_CC discharge_NN was_VBD round_JJ ,_, elastic_JJ ,_, unfixed_VBD to_TO the_DT subcutis_NN ,_, and_CC 6_CD by_IN 11_CD cm_NN in_IN size_NN ._SENT The_DT dog_NN was_VBD depressed_VBN and_CC showed_VBN dyspnea_NN ._SENT Furthermore_RB ,_, chest_NN radiographs_NNS revealed_VBD a_DT nodule_NN (_( 5_CD by_IN 5_CD cm_NN in_IN size_NN )_) at_IN the_DT anterior_JJ mediastinum_NN and_CC a_DT diffuse_JJ interstitial_JJ pattern_NN in_IN the_DT cranial_JJ lobes_NNS ._SENT Microscopic_JJ examination_NN of_IN a_DT biopsy_NN specimen_NN from_IN the_DT subcutaneous_JJ nodule_NN disclosed_VBN (_( i_NP )_) granulomatous_JJ inflammation_NN with_IN branching_VBG fungal_JJ hyphae_NNS without_IN clamp_NN connections_NNS and_CC (_( ii_NNS )_) many_JJ granules_NNS ._SENT Because_IN the_DT owner_NN refused_VBD surgery_NN or_CC other_JJ invasive_JJ procedures_NNS ,_, the_DT dog_NN was_VBD treated_VBN with_IN ketoconazole_NN at_IN 10_CD mg/kg_NN administered_VBN orally_RB once_IN a_DT day_NN for_IN 3_CD months_NNS ._SENT This_DT regimen_NN was_VBD chosen_VBN because_IN ketoconazole_NN is_VBZ an_DT antifungal_JJ drug_NN with_IN few_JJ adverse_JJ effects_NNS and_CC is_VBZ reasonably_RB priced_VBN ._SENT However_RB ,_, nodules_NNS did_VBD not_RB diminish_VB in_IN size_NN ._SENT Three_CD months_NNS later_RBR ,_, the_DT dog_NN died_VBD ._SENT No_DT autopsy_NN was_VBD performed_VBN ._SENT The_DT basidiomycetous_JJ fungus_NN Schizophyllum_NP commune_NN is_VBZ emerging_VBG as_IN one_CD of_IN the_DT important_JJ agents_NNS of_IN sinusitis_NN and_CC pneumonia_NN in_IN humans_NNS ;_: however_RB ,_, reports_NNS of_IN its_PP$ infection_NN of_IN animals_NNS have_VBP been_VBN lacking_VBG ._SENT The_DT diagnosis_NN of_IN this_DT infection_NN is_VBZ sometimes_RB difficult_JJ ,_, and_CC the_DT identification_NN of_IN the_DT isolate_NN is_VBZ uncertain_JJ ._SENT Clamp_NN connections_NNS on_IN hyphae_NNS in_IN tissues_NNS are_VBP often_RB missing_VBG ,_, and_CC fruiting_VBG bodies_NNS are_VBP usually_RB not_RB formed_VBN in_IN vitro_NN ._SENT The_DT fungus_NN is_VBZ identified_VBN only_RB when_WRB it_PP is_VBZ a_DT dikaryon_NN capable_JJ of_IN basidiocarp_NN production_NN ._SENT In_IN recent_JJ years_NNS ,_, molecular_JJ techniques_NNS have_VBP greatly_RB improved_VBN the_DT identification_NN of_IN S._NP commune_NN ._SENT Analysis_NN of_IN the_DT internal_JJ transcribed_VBN spacer_NN region_NN of_IN the_DT rRNA_NN genes_NNS has_VBZ been_VBN utilized_VBN for_IN identification_NN of_IN the_DT species_NN ._SENT The_DT present_JJ report_NN describes_VBZ the_DT first_JJ isolation_NN of_IN S._NP commune_NN from_IN a_DT dog_NN ._SENT The_DT clinical_JJ isolate_NN grew_VBD on_IN Sabouraud_NP 's_POS glucose_NN agar_NN at_IN 24C_JJ for_IN 1_CD week_NN ,_, and_CC its_PP$ colony_NN was_VBD white_JJ and_CC cottony_JJ ._SENT Microscopic_JJ examination_NN of_IN the_DT isolate_NN revealed_VBD hyaline_JJ hyphae_NNS 2.5_CD to_TO 3.0_CD mum_NN in_IN diameter_NN and_CC confirmed_VBD the_DT presence_NN of_IN clamp_NN connections_NNS and_CC tubercles_NNS ,_, indicating_VBG that_IN the_DT isolate_NN was_VBD a_DT basidiomycete_NN ._SENT To_TO identify_VB the_DT species_NN of_IN the_DT clinical_JJ isolate_NN ,_, molecular_JJ analysis_NN of_IN its_PP$ 25S_JJ large-subunit_NN ribosomal_JJ DNA_NN was_VBD carried_VBN out_RP ._SENT A_DT mycelial_JJ sample_NN (_( about_RB 10_CD mg_NN )_) of_IN the_DT isolate_NN was_VBD lysed_VBN in_IN lysis_NN buffer_NN consisting_VBG of_IN 0.1_CD %_NN Zymolyase_NP 100T_NP (_( Takara_NP ,_, Kyoto_NP ,_, Japan_NP )_) ,_, 0.1_CD mM_NP EDTA_NP ,_, 1_CD %_NN sodium_NN dodecyl_NN sulfate_NN ,_, 10_CD mM_NP Tris_NP hydrochloride_NN (_( pH_NN 8.0_CD )_) and_CC 0.3_CD %_NN 2-mercaptoethanol_JJ at_IN 37C_JJ for_IN 16_CD h._NP High-molecular-weight_NP DNA_NP was_VBD obtained_VBN from_IN this_DT mycelial_JJ sample_NN by_IN phenol_NN and_CC chloroform_NN extraction_NN ._SENT A_DT 100-ng_NP DNA_NP sample_NN dissolved_VBN in_IN TE_JJ buffer_NN (_( 10_CD mM_NP Tris-hydrochloride_NP [_SYM pH_NN 8.0_CD ]_SYM ,_, 1_CD mM_NP EDTA_NP )_) was_VBD used_VBN for_IN PCR_NP amplification_NN ._SENT The_DT genomic_JJ DNA_NN sample_NN was_VBD amplified_VBN by_IN PCR_NP in_IN a_DT reaction_NN mixture_NN (_( 30_CD mul_NN )_) containing_VBG 10_CD mM_NP Tris-HCl_NP (_( pH_NN 8.3_CD )_) ,_, 50_CD mM_NP KCl_NP ,_, 1.5_CD mM_NP MgCl_NP ,_, 0.001_CD %_NN gelatin_NN ,_, 200_CD mM_NNS each_DT deoxynucleoside_NN triphosphate_NN ,_, 1.0_CD U_NP of_IN Taq_NP polymerase_NN (_( Takara_NP )_) ,_, and_CC 0.5_CD mug_NN of_IN a_DT pair_NN of_IN primers_NNS ._SENT We_PP used_VBD the_DT 25S_JJ large-subunit_NN ribosomal_JJ DNA-specific_NP primer_NN for_IN typing_VBG ._SENT The_DT sequences_NNS of_IN the_DT 25S_JJ large-subunit_NN ribosomal_JJ DNAs_NP of_IN many_JJ species_NNS of_IN basidiomycetes_NNS have_VBP been_VBN deposited_VBN in_IN the_DT DNA_NP data_NN bank_NN of_IN Japan_NP (_( DDBJ_NP )_) ,_, including_VBG those_DT of_IN the_DT ribosomal_JJ DNA_NN internal_JJ transcribed_VBN spacer_NN region_NN ._SENT The_DT sequence_NN of_IN forward_RB primer_JJR S-1_NN was_VBD 5'-GCA_NP TAT_NP CAA_NP TAA_NP GCG_NP GAG_NP GAA_NP AAG-3_NP '_POS ,_, and_CC that_IN of_IN reverse_JJ primer_NN S-2_NN was_VBD 5'-GGT_NP CCG_NP TGT_NP TTC_NP AAG_NP ACG-3_NP '_POS ._SENT With_IN these_DT primers_NNS ,_, a_DT 600-bp_JJ fragment_NN containing_VBG the_DT coding_VBG sequence_NN of_IN the_DT 25S_JJ large-subunit_NN ribosomal_JJ DNA_NN was_VBD expected_VBN to_TO be_VB amplified_VBN ._SENT PCR_NP amplification_NN was_VBD carried_VBN out_RP for_IN 35_CD cycles_NNS consisting_VBG of_IN template_NN denaturation_NN (_( 1_CD min_NN at_IN 94C_NN )_) ,_, primer_JJR annealing_VBG (_( 2_CD min_NN at_IN 55C_NP )_) ,_, and_CC polymerization_NN (_( 3_CD min_NN at_IN 72C_NP )_) ._SENT The_DT PCR_NP product_NN was_VBD electrophoresed_VBN through_IN a_DT 2_CD %_NN agarose_NN gel_NN and_CC then_RB stained_VBN with_IN ethidium_NN bromide_NN ._SENT The_DT PCR_NP product_NN from_IN the_DT sample_NN was_VBD sequenced_VBN by_IN the_DT dideoxy-chain_NN termination_NN method_NN with_IN an_DT ABI_NP PRISM_NN 310_CD Genetic_NP Analyzer_NP (_( Perkin-Elmer_NP Corp._NP ,_, Norwalk_NP ,_, Conn._NP )_) ._SENT These_DT procedures_NNS were_VBD carried_VBN out_IN three_CD times_NNS ._SENT Amplification_NN of_IN the_DT sample_NN DNA_NN with_IN 25S_JJ large-subunit_NN ribosomal_JJ DNA_NP primers_NNS yielded_VBD a_DT fragment_NN of_IN about_RB 600_CD bp_NN ,_, consistent_JJ with_IN the_DT size_NN of_IN the_DT 25S_JJ ribosomal_JJ DNA_NN of_IN fungal_JJ species_NNS reported_VBD previously_RB ._SENT To_TO examine_VB homology_NN relationships_NNS between_IN the_DT 25S_JJ large-subunit_NN ribosomal_JJ DNA_NN of_IN a_DT reference_NN strain_NN of_IN S._NP commune_NN and_CC that_IN of_IN the_DT clinical_JJ isolate_NN ,_, we_PP used_VBD FASTA_NP database_NN analysis_NN in_IN DDBJ_NP ._SENT The_DT nucleotide_NN sequences_NNS of_IN the_DT 25S_JJ large-subunit_NN ribosomal_JJ DNAs_NP of_IN the_DT clinical_JJ isolate_NN and_CC a_DT reference_NN strain_NN of_IN S._NP commune_NN (_( DDBJ_NP accession_NN no_RB ._SENT )_) showed_VBD 99_CD %_NN similarity_NN ._SENT The_DT results_NNS were_VBD obtained_VBN three_CD times_NNS with_IN this_DT molecular_JJ system_NN ,_, and_CC the_DT isolate_NN was_VBD identified_VBN as_IN S._NP commune_NN ._SENT As_RB stated_VBN previously_RB ,_, the_DT lack_NN of_IN clamp_NN connections_NNS in_IN tissues_NNS is_VBZ not_RB an_DT unusual_JJ finding_NN and_CC the_DT case_NN reported_VBD herein_RB is_VBZ no_DT exception_NN ._SENT Moreover_RB ,_, morphological_JJ identification_NN is_VBZ made_VBN even_RB more_RBR difficult_JJ when_WRB strains_NNS exhibit_VBP an_DT inability_NN to_TO mate_NN ._SENT For_IN these_DT reasons_NNS ,_, we_PP attempted_VBD to_TO identify_VB our_PP$ isolate_NN by_IN comparing_VBG its_PP$ 25S_JJ large-subunit_NN rRNA_NN gene_NN sequence_NN with_IN that_DT of_IN a_DT known_VBN strain_NN of_IN S._NP commune_NN ._SENT Our_PP$ results_NNS help_VB to_TO confirm_VB observations_NNS by_IN Sigler_NP et_FW al._FW and_CC Buzina_NN et_FW al._FW indicating_VBG that_IN this_DT method_NN has_VBZ potential_JJ for_IN the_DT rapid_JJ identification_NN of_IN clinical_JJ isolates_NNS of_IN S._NP commune_NN ._SENT The_DT number_NN of_IN cases_NNS of_IN S._NP commune_NN infection_NN is_VBZ increasing_VBG in_IN both_DT immunocompetent_JJ and_CC immunocompromised_JJ humans_NNS ._SENT In_IN this_DT case_NN ,_, no_DT immunosuppressive_JJ condition_NN or_CC treatment_NN was_VBD recognized_VBN in_IN the_DT canine_JJ patient_NN ._SENT However_RB ,_, we_PP feel_VBP that_IN steroid_NN treatment_NN ,_, chemotherapy_NN ,_, and_CC immunosuppressive_JJ underlying_VBG diseases_NNS may_MD facilitate_VB subsequent_JJ infection_NN with_IN S._NP commune_NN in_IN dogs_NNS ._SENT Animal_JJ infection_NN with_IN S._NP commune_NN has_VBZ not_RB been_VBN reported_VBN as_RB far_RB as_IN we_PP know_VBP ,_, but_CC with_IN the_DT aid_NN of_IN molecular_JJ analysis_NN ,_, additional_JJ animal_NN cases_NNS can_MD be_VB found_VBN hereafter_RB ._SENT Nucleotide_NN sequence_NN accession_NN number_NN ._SENT |_SYM The_DT partial_JJ sequence_NN of_IN the_DT S._NP commune_NN clinical_JJ isolate_NN 25S_JJ large-subunit_NN rRNA_NN gene_NN reported_VBD in_IN this_DT paper_NN has_VBZ been_VBN deposited_VBN in_IN the_DT GenBank_NP database_NN and_CC assigned_VBN accession_NN no_RB ._SENT ._SENT FIG._NN 1_CD ._SENT |_SYM Chest_NP radiograph_NN revealing_VBG the_DT nodule_NN at_IN the_DT anterior_JJ mediastinum_NN and_CC a_DT diffuse_JJ interstitial_JJ pattern_NN in_IN the_DT cranial_JJ lobes_NNS ._SENT Chest_NN radiograph_NN revealing_VBG the_DT nodule_NN at_IN the_DT anterior_JJ mediastinum_NN and_CC a_DT diffuse_JJ interstitial_JJ pattern_NN in_IN the_DT cranial_JJ lobes_NNS ._SENT FIG._NN 2_CD ._SENT |_SYM Microscopic_JJ view_NN of_IN a_DT biopsy_NN specimen_NN from_IN a_DT nodule_NN on_IN the_DT neck_NN disclosing_VBG granulomatous_JJ inflammation_NN with_IN fungal_JJ branching_NN hyphae_NNS ._SENT Microscopic_JJ view_NN of_IN a_DT biopsy_NN specimen_NN from_IN a_DT nodule_NN on_IN the_DT neck_NN disclosing_VBG granulomatous_JJ inflammation_NN with_IN fungal_JJ branching_NN hyphae_NNS ._SENT FIG._NN 3_CD ._SENT |_SYM White_NP ,_, cottony_JJ colony_NN of_IN the_DT clinical_JJ isolate_NN ._SENT White_NP ,_, cottony_JJ colony_NN of_IN the_DT clinical_JJ isolate_NN ._SENT FIG._NN 4_CD ._SENT |_SYM Microscopic_JJ view_NN of_IN the_DT clinical_JJ isolate_NN revealing_VBG clamp_NN connections_NNS and_CC tubercles_NNS ._SENT Microscopic_JJ view_NN of_IN the_DT clinical_JJ isolate_NN revealing_VBG clamp_NN connections_NNS and_CC tubercles_NNS ._SENT 